The importance of impaired physical health and age in normal cognitive aging
- PMID: 17430364
- DOI: 10.1111/j.1467-9450.2007.00594.x
The importance of impaired physical health and age in normal cognitive aging
Abstract
The objective of this study was to investigate the importance of impaired physical health and age in normal cognitive aging. In our cross-sectional, clinical and explorative study, medical and neuropsychological data from 118 voluntary healthy controls aged 26-91 years were collected from five recruitment occasions. Health was assessed according to a criterion reflecting clinical and subclinical severity. The examinations included a clinical investigation, brain neuroimaging, and a comprehensive neuropsychological assessment. Regression analyses showed a significant incidence of clinical and subclinical medical disorders that explained 10.8% of the variation in cognitive performance, while age-related impairment explained 5.6%. Findings of the central nervous system were important but various other medical findings explained about half of the health-related variation. Cognitively demanding tasks were more susceptible to impaired physical health while tasks comprising salient motor- and visual spatial elements were more prone to be impaired by age. Our findings suggest (1) that impaired physical health is more important than chronological age in accounting for cognitive impairment across the adult lifespan, (2) that age and health dissociate with regard to cognitive functions affected, and (3) that selection for so-called "super healthy" elderly people might be justified in cognitive research. Because the prevalent diseases in normal aging are potentially preventable, the present findings promise good prospect for prevention of future cognitive disability among elderly people.
Similar articles
-
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French.
-
Nutrition and cognitive deficit in the elderly: a population study.Eur J Clin Nutr. 2001 Dec;55(12):1053-8. doi: 10.1038/sj.ejcn.1601270. Eur J Clin Nutr. 2001. PMID: 11781671
-
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262
-
[Plurality of patterns of cognitive impairment in normal aging and in dementia].Rev Neurol (Paris). 2000 Sep;156(8-9):759-66. Rev Neurol (Paris). 2000. PMID: 10992120 Review. French.
-
Behavioral determinants of healthy aging: good news for the baby boomer generation.Online J Issues Nurs. 2003;8(2):6. Online J Issues Nurs. 2003. PMID: 12795635 Review.
Cited by
-
Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness.Alzheimers Dement (Amst). 2017 Jun 9;8:156-164. doi: 10.1016/j.dadm.2017.05.006. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 28761926 Free PMC article.
-
Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?Front Aging Neurosci. 2022 Oct 5;14:905329. doi: 10.3389/fnagi.2022.905329. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36275006 Free PMC article.
-
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.Alzheimers Res Ther. 2018 May 10;10(1):45. doi: 10.1186/s13195-018-0374-y. Alzheimers Res Ther. 2018. PMID: 29747683 Free PMC article.
-
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.Brain. 2011 Jan;134(Pt 1):301-17. doi: 10.1093/brain/awq349. Epub 2010 Dec 13. Brain. 2011. PMID: 21149866 Free PMC article.
-
Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients.Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2120-6. doi: 10.1007/s00259-014-2859-7. Epub 2014 Jul 31. Eur J Nucl Med Mol Imaging. 2014. PMID: 25077930
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical